About us

 

Mabtech AB is a privately owned biotech company founded in 1986. Emerging from the Department of Immunology at Stockholm University, Mabtech has become a world leader in ELISpot and T-cell measurements.

Representing one of the most sensitive and easiest methods to analyze specific T-cell responses, the ELISpot is ideal whenever studying the role of T cells in e.g. infections, cancer, allergy and autoimmune disease. With its straightforward performance and the possibility to screen large number of samples, the ELISpot has become a standard method in the research and clinical evaluations of new vaccines. 

To supplement the ELISpot products, we have recently launched a series of complete, ready-to-use ELISA kits that allow easy measurements of cytokine levels in various samples including serum and plasma.

By combining innovative development and high quality, our aim is to continue providing products that meet the needs of the frontline researcher as well as those involved in clinical research with high demands for large scale screening under standardized conditions.

With a highly competent and dedicated staff, we strive to always offer the best quality products and the best possible technical support. The head office and research laboratory are located in Stockholm but in order to work closely with the research community and to be able to offer fast deliveries world-wide we also have local offices in Australia, France, Germany and the USA. In several other countries we work via selected distributors.